secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2026-08-04T21:25:40+00:00
Accession:  0001493152-26-036032
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa shareholders approve 200,000-share increase to 2019 Omnibus Incentive Plan at annual meeting
--------------------------------------------------------------------------------

- All six director nominees elected with votes for ranging from 696,796 to 710,505; broker non-votes 825,288.
- Amendment to 2019 Omnibus Incentive Plan to increase shares by 200,000 approved: 579,877 for, 152,958 against, 2,700 abstain.
- Ratification of Cherry Bekaert as auditor: 1,541,664 for, 12,770 against, 6,389 abstain.
- Advisory say-on-pay approved: 640,726 for, 89,886 against, 4,923 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315226036032/0001493152-26-036032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315226036032/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-036032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer